Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Dec 15, 2017. Jaap Laufer.

Executive Summary

Emergo's Jaap Laufer says the oncoming Medical Device and IVD Regulations have serious flaws that could lead to the demise of the EU notified body system. Check out what he says might result.

"In my opinion, the notified body system for medical devices is bound to disappear under a successor piece of legislation that will establish an 'EMDA,' a European Medical Devices Agency that will absorb the major notified bodies, as we know them, into national agencies."  Jaap Laufer, medical director, Emergo

> Find out more: MDR And IVDR Fail Risk-Benefit Assessment, EU Reg Expert Says

Click here for a free trial of Medtech Insight

 

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT121929

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel